This approach suits individuals who experienced significant side effects on tirzepatide and want to ensure medication levels drop before introducing semaglutide
On September 30th, the FDA removed tirzepatide (the active ingredient in Mounjaro) from its shortage list, effectively barring compounding pharmacies from producing it
Treatment with broad-spectrum ABX, including ampicillin, metronidazole, neomycin, and vancomycin, dramatically increased GLP-1 levels in the serum (Fig
Standard escalation approach The typical retatrutide dose escalation starts low and increases over several weeks
No commercial ties We dont sell, supply, or link to suppliers of any medicine, and arent affiliated with any manufacturer